We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

41 hedge funds and large institutions have $17.1M invested in Anixa Biosciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more capital invested

Capital invested by funds: $9.95M → $17.1M (+$7.14M)

55% more call options, than puts

Call options by funds: $99K | Put options by funds: $64K

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0.61% more ownership

Funds ownership: 10.73% → 11.33% (+0.61%)

9% less funds holding

Funds holding: 45 → 41 (-4)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
7
Closed
8
Calls
$99K
Puts
$64K
Net Calls
+$35K
Net Calls Change
-$71K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$793K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$89.6K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$85.8K
4
Millennium Management
Millennium Management
New York
+$69.1K
5
UBS Group
UBS Group
Switzerland
+$66K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$116K
2
CL
CPWM LLC
Washington
-$61K
3
Charles Schwab
Charles Schwab
California
-$46.3K
4
VF
Virtu Financial
New York
-$45K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$66K +$38.4K +9,464 +240%
Charles Schwab
27
Charles Schwab
California
$63K -$46.3K -11,431 -47%
Simplex Trading
28
Simplex Trading
Illinois
$60K +$39.3K +9,686 +371%
ATC
29
Adirondack Trust Company
New York
$34K – – –
First Manhattan
30
First Manhattan
New York
$31K – – –
TWM
31
Tradition Wealth Management
Minnesota
$25K – – –
AA
32
Ancora Advisors
Ohio
$10K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$5K +$45 +11 +1%
Osaic Holdings
34
Osaic Holdings
Arizona
$4K -$3.65K -900 -47%
JP Morgan Chase
35
JP Morgan Chase
New York
$3K – – –
LFG
36
Larson Financial Group
Missouri
$3K – – –
Wells Fargo
37
Wells Fargo
California
$3K – – –
US Bancorp
38
US Bancorp
Minnesota
$2K – – –
TAM
39
Tucker Asset Management
Colorado
$560 – – –
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$477 +$393 +97 New
BC
41
Barrett & Company
Rhode Island
$340 +$324 +80 New
CL
42
CPWM LLC
Washington
– -$61K -20,000 Closed
VF
43
Virtu Financial
New York
– -$45K -14,738 Closed
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
– -$27K -8,675 Closed
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
– -$15K -5,000 Closed
TRCT
46
Tower Research Capital (TRC)
New York
– -$4K -1,452 Closed
VVP
47
Venture Visionary Partners
Ohio
– -$1.38K -450 Closed
FSWA
48
Financial Synergies Wealth Advisors
Texas
– -$306 -100 Closed
1
2

ANIX Hedge Fund Activity: Q3 2022 in Review

41 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2022, worth a combined $17.1M — up 72% from $9.95M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ANIX and 5 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 10 added.

The largest buyer was BlackRock, adding an estimated $793K. The largest seller was Renaissance Technologies, cutting an estimated $116K.

  • 41 institutional investors held Anixa Biosciences (ANIX) as of Q3 2022, down from 45 in Q2 2022.
  • Funds reported $17.1M of Anixa Biosciences stock for Q3 2022, up 72% quarter-over-quarter.
  • 5 funds opened new Anixa Biosciences positions in Q3 2022 and 8 closed out, a net change of -3 holders.
  • The largest Anixa Biosciences buyer in Q3 2022 was BlackRock, an estimated $793K added.
  • The largest Anixa Biosciences seller in Q3 2022 was Renaissance Technologies, an estimated $116K sold.

Based on aggregated 13F filings for Q3 2022.